These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18701831)

  • 21. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of long-term psychodynamic psychotherapy, fluoxetine and their combination in the outpatient treatment of depression.
    Bastos AG; Guimaraes LS; Trentini CM
    Psychother Res; 2015; 25(5):612-24. PubMed ID: 25041333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-Term Psychodynamic Psychotherapy with Mentalization-Based Techniques in Major Depressive Disorder patients: Relationship among alexithymia, reflective functioning, and outcome variables - A Pilot study.
    Bressi C; Fronza S; Minacapelli E; Nocito EP; Dipasquale E; Magri L; Lionetti F; Barone L
    Psychol Psychother; 2017 Sep; 90(3):299-313. PubMed ID: 27801544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.
    Muhonen LH; Lönnqvist J; Juva K; Alho H
    J Clin Psychiatry; 2008 Mar; 69(3):392-9. PubMed ID: 18348597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder.
    Papakostas GI; Petersen T; Sklarsky KG; Nierenberg AA; Alpert JE; Fava M
    Psychiatry Res; 2007 Jan; 149(1-3):195-200. PubMed ID: 17157390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimensional personality traits and treatment outcome in patients with major depressive disorder.
    Quilty LC; De Fruyt F; Rolland JP; Kennedy SH; Rouillon PF; Bagby RM
    J Affect Disord; 2008 Jun; 108(3):241-50. PubMed ID: 18067975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
    Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
    J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled double-blind trial of phenytoin vs. fluoxetine in major depressive disorder.
    Nemets B; Bersudsky Y; Belmaker RH
    J Clin Psychiatry; 2005 May; 66(5):586-90. PubMed ID: 15889944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.
    Judd LL; Rapaport MH; Yonkers KA; Rush AJ; Frank E; Thase ME; Kupfer DJ; Plewes JM; Schettler PJ; Tollefson G
    Am J Psychiatry; 2004 Oct; 161(10):1864-71. PubMed ID: 15465984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
    Sechter D; Troy S; Paternetti S; Boyer P
    Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined treatment of major depression in patients with borderline personality disorder: a comparison with pharmacotherapy.
    Bellino S; Zizza M; Rinaldi C; Bogetto F
    Can J Psychiatry; 2006 Jun; 51(7):453-60. PubMed ID: 16838827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does early response predict outcome in psychotherapy and combined therapy for major depression?
    Van HL; Schoevers RA; Kool S; Hendriksen M; Peen J; Dekker J
    J Affect Disord; 2008 Jan; 105(1-3):261-5. PubMed ID: 17521743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
    Fava M; Schaefer K; Huang H; Wilson A; Iosifescu DV; Mischoulon D; Wessel TC
    J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a dose-effect relationship between the number of psychotherapy sessions and improvement of social functioning?
    Molenaar PJ; Boom Y; Peen J; Schoevers RA; Van R; Dekker JJ
    Br J Clin Psychol; 2011 Sep; 50(3):268-82. PubMed ID: 21810106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features.
    Sheehan DV; Nemeroff CB; Thase ME; Entsuah R;
    Int Clin Psychopharmacol; 2009 Mar; 24(2):61-86. PubMed ID: 19238088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
    Goldstein DJ; Mallinckrodt C; Lu Y; Demitrack MA
    J Clin Psychiatry; 2002 Mar; 63(3):225-31. PubMed ID: 11926722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.
    Hale A; Corral RM; Mencacci C; Ruiz JS; Severo CA; Gentil V
    Int Clin Psychopharmacol; 2010 Nov; 25(6):305-14. PubMed ID: 20856123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined brief dynamic therapy and pharmacotherapy in the treatment of major depressive disorder: a pilot study.
    Maina G; Rosso G; Crespi C; Bogetto F
    Psychother Psychosom; 2007; 76(5):298-305. PubMed ID: 17700050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder.
    Schmidt ME; Fava M; Robinson JM; Judge R
    J Clin Psychiatry; 2000 Nov; 61(11):851-7. PubMed ID: 11105738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.